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Table S1. 
1
H NMR (400 MHz, DMSO-d6) chemical shifts (δ in ppm) of H2L
1-5 
and [Mo2
V
O2L2
1-4
] 
(1-4) and [Mo
VI
O2L
5
] (5) 
 
 
 
Compounds OH 
(phenolic) 
CH 
(azomethine) 
OCH3 Aromatic 
protons 
Aliphatic protons 
H2L
1
 12.96 (s, 1H) 8.94 (s, 1H) - 6.96–7.68 (m, 
6H) 
- 
[Mo2
V
O2L
ʹ
2
1
] 
(1) 
- 9.78 (s, 1H) - 6.998.10  (m, 
8H) 
- 
H2L
2
 13.01 (s, 1H) 8.91 (s, 1H) 3.73 (s, 3H) 6.89–7.46 (m, 
5H) 
- 
[Mo2
V
O2L
ʹ
2
2
] 
(2) 
- 9.76 (s, 1H) 4.04 (s, 3H) 6.917.48 (m, 
7H) 
- 
H2L
3
 12.96 (s, 1H) 8.92 (s, 1H) - 6.93–7.92 (m, 
5H) 
- 
[Mo2
V
O2L
ʹ
2
3
] 
(3) 
- 9.09 (s, 1H) - 6.68–7.91 (m, 
7H) 
- 
H2L
4
 15.13 (s, 1H) 9.68 (s, 1H) - 7.38–8.54 (m, 
8H) 
- 
[Mo2
V
O2L
ʹ
2
4
] 
(4) 
- 10.29 (s, 1H) - 7.13–8.77 (m, 
10H) 
- 
H2L
5
 13.61 (s, 2H) 8.55 (s, 1H) 
8.52 (s, 1H) 
3.75 (s, 6H) 6.75–7.02 (m, 
6H) 
 
3.73 (d, 2H, -CH2) 
3.77 (m, 1H, CH)  
1.31 (d, 3H, -CH3) 
[Mo
VI
O2L
5
] 
(5) 
- 8.80 (s, 1H) 
7.33 (s, 1H) 
7.32 (s, 1H) 
7.31 (s, 1H) 
3.613.75 
(m, 12H) 
6.687.31 (m, 
12H) 
0.761.49  
(m, 8H, -CH3, 
CH ) 
3.784.33  
(m, 4H, -CH2 ) 
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Table S2. Binding constant (Kb) values for the "CT-DNA-ligand" interactions.
a
 
 
 
 
 
 
 
 
 
 
a
 The DNA binding constant was determined by the UV-Vis spectral method. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ligand  Binding constant (Kb) (M
-1
) 
H2L
1
 2.23  10
3
 
H2L
2
 1.70  103 
H2L
3
 1.15  103 
H2L
4
 6.75  103 
H2L
5
 2.77  10
4
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Figure S1. (A) Absorption spectral traces of the complexes 1 (a), 2 (b), 3 (c), 4 (d) and 5 (e) (25 
μM each) in 10 mM Tris-HCl buffer (pH 8.0) containing 1% DMF. The spectra were recorded up 
to 72 h at room temperature 
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(B) 
 
Figure S1. (B) 
1
H NMR spectra of complex 2 in DMSO-d6 after 0 h (a) 1H NMR spectra of 
complex 2 in DMSO-d6 after 72 h (b) and after heating (120°C) the solution (c). 
 
 
b 
c 
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Figure S1. (C) UV-vis spectra of the complexes (1‒5) (5 µM) [A] in DMSO and [B] in DMSO 
and water. 
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Figure S2. FTIR spectra of (a): [Mo
V
O(HL4)(OEt)] (Id
4
)  and (b) [Mo2
V
O2L2
4
] (4). 
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Figure S3. Absorbance spectra of (a): [Mo
V
O(HL4)(OEt)] (Id
4
)  and (b): [Mo2
V
O2L2
4
] (4). 
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Figure S4. 
1
HNMR spectra of (a) H2L
2 
(b) [Mo2
V
O2L2
2
] (2). 
N
NH
O
Mo
Mo
N
N H
O
O
O
O
O
NN
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O O
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Figure S5. 
1
H NMR spectrum of [Mo2
V
O2L2
3
] (3). 
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Figure S6. 
13
C NMR spectrum of [Mo2
VI
O2L2
3
] (3). 
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Figure S7. ESI-MS of [Mo2
V
O2L2
3
] (3). 
 
[(M-H)+] 
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Figure S8. Cyclic voltammogram (anodic region) of [Mo
V
O(HL4)(OEt)] (Id
4
). 
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Figure S9. Electronic absorption spectra for H2L
1
 (a), H2L
2 
(b), H2L
3
 (c) H2L
4
 (d) and H2L
5
 (e) (25 
μM each) upon the titration of CT-DNA (0 – 250 μM) in 10 mM Tris-HCl buffer (pH 8.0) 
containing 1% DMF. The inset shows the linear fit of [DNA]/(εa - εf) vs [DNA] from which the 
binding constant (Kb) was calculated using Eq. 1 (see main text). 
300 375 450 525 600
0.0
0.2
0.4
0.6
0.8
50 100 150 200 250
4
5
6
7a
A
b
s
o
rb
a
n
c
e
 (
a
.u
.)
Wavelength (nm)
[D
N
A
]/

a
-
f)
 x
 1
0
-9
 M
[DNA] x 10-6 M
300 375 450 525 600
0.0
0.1
0.2
0.3
0.4
50 100 150 200 250
8
9
10
11b
A
b
s
o
rb
a
n
c
e
 (
a
.u
.)
Wavelength (nm)
[D
N
A
]/

a
-
f)
 x
 1
0
-9
 M
[DNA] x 10-6 M
300 375 450 525 600
0.0
0.2
0.4
0.6
50 100 150 200 250
15
30
45
60
c
A
b
s
o
rb
a
n
c
e
 (
a
.u
.)
Wavelength (nm)
[D
N
A
]/

a
-
f)
 x
 1
0
-9
 M
[DNA] x 10-6 M
300 375 450 525 600
0.0
0.1
0.2
0.3
0.4
50 100 150 200 250
50
100
150
200
d
A
b
s
o
rb
a
n
c
e
 (
a
.u
.)
Wavelength (nm)
[D
N
A
]/

a
-
f)
 x
 1
0
-9
 M
[DNA] x 10-6 M
300 375 450 525 600
0.0
0.1
0.2
0.3
0.4
0.5
50 100 150 200 250
4
8
12e
A
b
s
o
rb
a
n
c
e
 (
a
.u
.)
Wavelength (nm)
[D
N
A
]/

a
-
f)
 x
 1
0
-9
 M
[DNA] x 10-6 M
S15 
240 280 320 360 400
-8
-4
0
4
8
 
 
E
ll
ip
ti
c
it
y
 (
m
D
e
g
)
Wavelength (nm)
 CT-DNA
 1
 2
 3
 4
 5
 
Figure S10. Circular dichroism spectra of CT-DNA (100 μM) in the presence and absence of 
complexes 15 (25 µM each). The experiment was done in 10 mM Tris-HCl buffer (pH 8.0) 
containing 1% DMF. The path length of the cuvette was 10 mm. 
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Figure S11. Gel diagram showing concentration dependent DNA cleavage by 1–5; 300 ng of SC 
pUC19 DNA at different concentrations of the complexes [1–100 µM in 50 mM Tris-HCl buffer 
(pH 8.0) containing 1% DMF] was photo-irradiated with UVA at 350 nm for 3 h. Lanes 1–8: 1, 
2.5, 5.0, 7.5, 10, 50, 75, and 100 µM of 1–5. 
 
 
 
 
 
 
 
 
 
S17 
 
 
 
 
Figure S12. Gel diagram showing the effect of DMF (1%) and ligands on the photo-induced 
cleavage of SC pUC19 DNA. 300 ng SC pUC19 DNA was photo-irradiated in absence and 
presence of 1% DMF and various ligands (50 μM) with UVA at 350 nm for 3 h. Lane 1, DNA 
only; Lane 2, DNA in presence of 1% DMF; Lane 3, DNA + H2L
1
; Lane 4, DNA + H2L
2
; Lane 5, 
DNA + H2L
3
; Lane 6, DNA + H2L
4
; Lane 7, DNA + H2L
5
. 
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Figure S13. DNA cleavage of SC pUC19 DNA by 1–5 in presence of various additives in 50 mM 
Tris-HCl buffer (pH 8.0) containing 1% DMF. SC pUC19 DNA (300 ng) in the presence of 
various additives was photo-irradiated with UVA at 350 nm for 3 h in presence of 1–5 (50 µM). 
The additive concentrations were: sodium azide (0.5 mM), L-histidine (0.5 mM), KI (0.5 mM) and 
D-mannitol (0.5 mM). 
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Figure S14. Gel diagram depicting cleavage of SC pUC19 DNA by 1–5 in presence of various 
additives in 50 mM Tris-HCl buffer (pH 8.0) containing 1% DMF. SC pUC19 DNA (300 ng) in 
the presence of various additives was photo-irradiated at 350 nm for 3 h with 1–5 (50 µM). The 
additive concentrations were: sodium azide (0.5 mM), L-histidine (0.5 mM), KI (0.5 mM) and D-
mannitol (0.5 mM). Lane 1, DNA + complex; Lane 2, DNA + complex + sodium azide; Lane 3, 
DNA + complex + L-histidine; Lane 4, DNA + complex + KI; Lane 5, DNA + complex + D -
mannitol. 
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Figure S15. Effect of 1–5 on cell viability and growth: HaCaT cells were treated with different 
concentrations of the test compound for 48 h and then cell viability was measured by MTT assay. 
Data reported as the mean ± SD for n=3. 
 
 
 
 
 
 
 
 
 
0
50
100
%
 C
el
l v
ia
b
ili
ty
 
Metal Complexes 
5 µM
10 µM
25 µM
50 µM
S21 
 
 
 
 (a)     (b) 
  
Figure S16 (A).  Control of MCF-7 cells.  
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 (a)      5 µM                          10 µM                           25 µM                           50 µM  
 
(b)  
 
Figure S16 (B). Effect of treatment of complexes on the nuclear morphology of MCF-7 cells. The 
morphological changes in nuclei of MCF-7 cells from control and treated groups were washed 
twice with PBS (pH 7.4) and fixed after incubation for 15 min with 3.7 % of formaldehyde. The 
cells were then washed twice with PBS and treated with 0.2% triton-X 100 in PBS for 30 seconds. 
Further the cells were washed twice with PBS and PI solution (10 µg/mL) was added and kept for 
15 min in dark. Finally, the cells were washed twice with PBS and imaged under fluorescence 
microscope (FLoid, Life technologies). Arrows indicate the morphological changes in nuclei of 
MCF–7 cells observed on applying increasing concentrations (5, 10, 25 and 50 µM) of 1 in 
comparison to control. The scale bar corresponds to 100 μm. 
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(a)      5 µM                          10 µM                           25 µM                           50 µM 
(b)                        
 
Figure S16 (C). Effect of treatment of complexes on the nuclear morphology of MCF-7 cells. The 
morphological changes in nuclei of MCF-7 cells from control and treated groups were washed 
twice with PBS (pH 7.4) and fixed after incubation for 15 min with 3.7 % of formaldehyde. The 
cells were then washed twice with PBS and treated with 0.2% triton-X 100 in PBS for 30 seconds. 
Further the cells were washed twice with PBS and PI solution (10 µg/mL) was added and kept for 
15 min in dark. Finally, the cells were washed twice with PBS and imaged under fluorescence 
microscope (FLoid, Life technologies). Arrows indicate the morphological changes in nuclei of 
MCF–7 cells observed on applying increasing concentrations (5, 10, 25 and 50 µM) of 3 in 
comparison to control. The scale bar corresponds to 100 μm. 
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(a)      5 µM                          10 µM                           25 µM                           50 µM 
(b) 
                    
Figure S16 (D). Effect of treatment of complexes on the nuclear morphology of MCF-7 cells. The 
morphological changes in nuclei of MCF-7 cells from control and treated groups were washed 
twice with PBS (pH 7.4) and fixed after incubation for 15 min with 3.7 % of formaldehyde. The 
cells were then washed twice with PBS and treated with 0.2% triton-X 100 in PBS for 30 seconds. 
Further the cells were washed twice with PBS and PI solution (10 µg/mL) was added and kept for 
15 min in dark. Finally, the cells were washed twice with PBS and imaged under fluorescence 
microscope (FLoid, Life technologies). Arrows indicate the morphological changes in nuclei of 
MCF–7 cells observed on applying increasing concentrations (5, 10, 25 and 50 µM) of 4 in 
comparison to control. The scale bar corresponds to 100 μm. 
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 (a)         5 µM                          10 µM                           25 µM                           50 µM 
(b) 
 
Figure S16 (E). Effect of treatment of complexes on the nuclear morphology of MCF-7 cells. The 
morphological changes in nuclei of MCF-7 cells from control and treated groups were washed 
twice with PBS (pH 7.4) and fixed after incubation for 15 min with 3.7 % of formaldehyde. The 
cells were then washed twice with PBS and treated with 0.2% triton-X 100 in PBS for 30 seconds. 
Further the cells were washed twice with PBS and PI solution (10 µg/mL) was added and kept for 
15 min in dark. Finally, the cells were washed twice with PBS and imaged under fluorescence 
microscope (FLoid, Life technologies). Arrows indicate the morphological changes in nuclei of 
MCF–7 cells observed on applying increasing concentrations (5, 10, 25 and 50 µM) of 5 in 
comparison to control. The scale bar corresponds to 100 μm. 
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(a)                                                          (b) 
 
 
 
 
 
 
 
Figure S17 (A).  Control of HCT-15 cells            
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A)  
 
 
 
(b)                   
                                                                                               
 
 
 
 
 
 
 
 
Figure S17 (B). Effect of treatment of complexes on the nuclear morphology of HCT-15 cells. 
The morphological changes in nuclei of HCT-15 cells from control and treated groups were 
washed twice with PBS (pH 7.4) and fixed after incubation for 15 min with 3.7 % of 
formaldehyde. The cells were then washed twice with PBS and treated with 0.2% triton-X 100 in 
PBS for 30 seconds. Further the cells were washed twice with PBS and PI solution (10 µg/mL) 
was added and kept for 15 min in dark. Finally, the cells were washed twice with PBS and imaged 
under fluorescence microscope (Olympus IX 70). Arrows indicate the morphological changes in 
nuclei of HCT-15 cells observed on applying increasing concentrations (5, 10, 25 and 50 µM) of 1 
in comparison to control. The scale bar corresponds to 50 μm. 
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        5µM                             10µM                                    25µM                                  50 µM            
(a)        
 
 
 
 
 
 
 
 
                                                                                                             
(b) 
 
 
 
 
 
 
 
  
Figure S17 (C). Effect of treatment of complexes on the nuclear morphology of HCT-15 cells. 
The morphological changes in nuclei of HCT-15 cells from control and treated groups were 
washed twice with PBS (pH 7.4) and fixed after incubation for 15 min with 3.7 % of 
formaldehyde. The cells were then washed twice with PBS and treated with 0.2% triton-X 100 in 
PBS for 30 seconds. Further the cells were washed twice with PBS and PI solution (10 µg/mL) 
was added and kept for 15 min in dark. Finally, the cells were washed twice with PBS and imaged 
under fluorescence microscope (Olympus IX 70). Arrows indicate the morphological changes in 
nuclei of HCT-15 cells observed on applying increasing concentrations (5, 10, 25 and 50 µM) of 3 
in comparison to control. The scale bar corresponds to 50 μm. 
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Figure S17 (D). Effect of treatment of complexes on the nuclear morphology of HCT-15 cells. 
The morphological changes in nuclei of HCT-15 cells from control and treated groups were 
washed twice with PBS (pH 7.4) and fixed after incubation for 15 min with 3.7 % of 
formaldehyde. The cells were then washed twice with PBS and treated with 0.2% triton-X 100 in 
PBS for 30 seconds. Further the cells were washed twice with PBS and PI solution (10 µg/mL) 
was added and kept for 15 min in dark. Finally, the cells were washed twice with PBS and imaged 
under fluorescence microscope (Olympus IX 70). Arrows indicate the morphological changes in 
nuclei of HCT-15 cells observed on applying increasing concentrations (5, 10, 25 and 50 µM) of 4 
in comparison to control. The scale bar corresponds to 50 μm. 
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Figure S17 (E). Effect of treatment of complexes on the nuclear morphology of HCT-15 cells. 
The morphological changes in nuclei of HCT-15 cells from control and treated groups were 
washed twice with PBS (pH 7.4) and fixed after incubation for 15 min with 3.7 % of 
formaldehyde. The cells were then washed twice with PBS and treated with 0.2% triton-X 100 in 
PBS for 30 seconds. Further the cells were washed twice with PBS and PI solution (10 µg/mL) 
was added and kept for 15 min in dark. Finally, the cells were washed twice with PBS and imaged 
under fluorescence microscope (Olympus IX 70). Arrows indicate the morphological changes in 
nuclei of HCT-15 cells observed on applying increasing concentrations (5, 10, 25 and 50 µM) of 5 
in comparison to control. The scale bar corresponds to 50 μm. 
 
